“…Coated MAPs have been evaluated with several different vaccine types (e.g., live attenuated, viral vector, inactivated virus, subunit, DNA, and VLPs) for numerous viral infections, such as influenza, hepatitis B, rotavirus, RSV, Ebola, dengue, measles, polio, HIV, HPV, West Nile virus, chikungunya, HSV, and hepatitis C [ 270 , [275] , [276] , [277] , [278] , [279] , [280] , [281] , [282] , [283] , [284] , [285] , [286] , [287] , [288] , [289] , [290] , [291] , [292] , [293] , [294] , [295] , [296] , [297] , [298] , [299] , [300] , [301] , [302] , [303] ]. Vaccines delivered by coated MAPs have been mainly tested in mice, but there also have been a limited number of studies in rat, guinea pig, porcine, and non-human primate models [ 221 , 291 , 294 , 296 , 304 , 305 ].…”